Thursday, October 25
11:00 a.m. - 1:30 p.m.
Topics include: Attention-Deficit/Hyperactivity Disorder, Biochemistry, Disruptive Behavior Disorders, Mood Disorder/Suicidal Behavior
B1
Effects of Atomoxetine on Sexual Development in Children and Adolescents with ADHD
Thomas J. Spencer, M.D. (M)
Massachusetts General Hospital
Boston, MA
Paula T. Trzepacz, M.D.
Michael M. Witte, Ph.D.
Shuyu Zhang, M.S.
Mark E. Bangs, M.D. (M)
B2
Cardiovascular Safety of Dexmethylphenidate Extended Release in Children with ADHD
Thomas J. Spencer, M.D. (M)
Massachusetts General Hospital
Boston, MA
Rafael Muniz, M.D.
Matthew Brams, M.D. (M)
Samuel W. Boellner, M.D.
Michael S. Greenbaum, M.D. (M)
Ortrud Gerstner, M.Sc.
Mary Borello, R.N.
Anuradha Thulasiraman, M.A.
Anke Post, M.D.
B3
Methylphenidate in Bipolar Disorder and Co-Morbid Attention Deficit/Hyperactivity Disorder
Robert L. Findling, M.D. (M)
University Hospitals of Cleveland-Case Western Reserve University
Cleveland, OH
Nora K. McNamara, M.D.
Christine A. Demeter, M.A.
Robert J. Stansbrey, M.D.
Barbara L. Gracious, M.D. (M)
Resaca E. Whipkey, M.A.
Michael Manos, Ph.D.
Joseph R. Calabrese, M.D.
Elizabeth J. Short, Ph.D.
B4
Cardiovascular Effects of the Methylphenidate Transdermal System in ADHD Subjects
Robert L. Findling, M.D. (M)
University Hospitals of Cleveland-Case Western Reserve University
Cleveland, OH
Samuel W. Boellner, M.D.
John C. Burnside, M.D. (M)
Jonathon Rubin, M.D., M.B.A.
B5
Fluoxetine Versus Placebo Treatment of Depression and Co-Morbid Substance Use
Robert L. Findling, M.D. (M)
University Hospitals of Cleveland-Case Western Reserve University
Cleveland, OH
Nora K. McNamara, M.D.
Robert J. Stransbery, M.D.
Christine A. Demeter, M.A.
Jacqui Lingler, B.A.
Jon Faber, M.A.
Maria Pagano, Ph.D.
B6
Efficacy of Aripiprazole in Children (10-17 years old) with Mania
Kiki D. Chang, M.D. (M)
Stanford University School of Medicine
Stanford, CA
Margaretta Nyilas, M.D.
Catherine Aurang, B.S.
Alet van Beek, B.Sc. (H
Na Jin, MS
Ronald Marcus, M.D.
Robert A. Forbes, Ph.D.
William H. Carson, M.D.
Arif Kahn, M.D. (M)
Robert L. Findling, M.D. (M)
B7
Safety and Tolerability of Aripiprazole in Children (10-17 years old) with Mania
Christoph U. Correll, M.D. (M)
Zucker Hillside Hospital
Glen Oaks, NY
Margaretta Nyilas, M.D.
Catherine Aurang, B.S.
Alet van Beek, B.Sc. (H
Na Jin, MS
Ronald Marcus, M.D.
Robert A. Forbes, Ph.D.
Robert D. McQuade, Ph.D.
Taro Iwamoto, Ph.D.
Elizabeth B. Weller, M.D. (M)
B8
Exploratory Factor Analysis of the CDRS-R in Youths with ADHD
W. Burleson Daviss, M.D. (M)
University of Texas Health Science Center
San Antonio, TX
Fabiano G. Nery, M.D.
Rene L. Olvera, M.D., M.P.H. (M)
Rasim Somer Diler, M.D. (M)
Kelin M. Mezzomo, M.D.
Jair C. Soares, M.D.
B9
Early Pharmacotherapy for ADHD Protects Against Risk of Later Depression
W. Burleson Daviss, M.D. (M)
University of Texas Health Science Center
San Antonio, TX
Rasim Somer Diler, M.D. (M)
Boris Birmaher, M.D. (M)
James Mintz, Ph.D.
B10
Efficacy of Quetiapine in Children and Adolescents with Bipolar Mania
Melissa P. DelBello, M.D. (M)
University of Cincinnati College of Medicine
Cincinnati, OH
Robert L. Findling, M.D. (M)
Willie R. Earley, M.D.
Jill Stankowski, M.S.
Larisa D. Acevedo, Ph.D.
B11
Risperidone Monotherapy and Improvement in ADHD Symptoms in Pediatric Bipolar Disorder
Robert Lloyd Doyle, M.D. (M)
Massachusetts General Hospital
Boston, MA
B12
Burden of Painful Symptoms of Depression in Pediatric Bipolar Disorder
Benjamin I. Goldstein, M.D., Ph.D. (M)
Western Psychiatric Institute & Clinic
Pittsburgh, PA
David A. Axelson, M.D. (M)
Boris Birmaher, M.D. (M)
Martin B. Keller, M.D.
Michael A. Strober, Ph.D.
B13
Impact of Comorbid Disorders in Bipolar Parents on Psychopathology in Offspring
Aude Henin, Ph.D.
Massachusetts General Hospital
Boston, MA
Eric O. Mick, Sc.D.
Joseph Biederman, M.D. (M)
Jamie A. Micco, Ph.D.
Claire A. Tilley, B.A.
Laura Rindlaub, B.A.
Gary Sachs, M.D.
Andrew Nierenberg, M.D.
B14
Is Psychopharmacologic Treatment Associated with Neuropsychological Deficits in Bipolar Youth
Aude Henin, Ph.D.
Massachusetts General Hospital
Boston, MA
B15
Open-Label Treatment with Olanzapine in Adolescents with Bipolar Mania
Wen I Xu, Ph.D.
Lilly Research Laboratories
Indianapolis, IN
Mauricio Tohen, M.D., Dr.PH
Ludmila Kryzhanovskaya, M.D., Ph.D.
Gabrielle A. Carlson, M.D. (M)
Melissa P. DelBello, M.D. (M)
Janet Wozniak, M.D.
Robert A. Kowatch, M.D. (M)
Karen Dineen Wagner, M.D., Ph.D. (M)
Robert L. Findling, M.D. (M)
Daniel Lin, Ph.D.
Carol Robertson-Plouch, D.V.M.
Ralf W. Dittmann, M.D., Ph.D.
Joseph Biederman, M.D. (M)
B16
Young Mania Rating Scale Scores Across Twelve Research Groups
Eric A. Youngstrom, Ph.D.
University of North Carolina
Greensboro, NC
Megan F. Joseph, B.A.
Robert L. Findling, M.D. (M)
Jair C. Soares, M.D.
Gabrielle A. Carlson, M.D. (M)
Vivian Kafantaris, M.D. (M)
Janet Wozniak, M.D.
Kiki D. Chang, M.D. (M)
Jean A. Frazier, M.D. (M)
Mary A. Fristad, Ph.D., ABPP
Melissa P. DelBello, M.D. (M)
Robert A. Kowatch, M.D. (M)
Russell E. Scheffer, M.D. (M)
Ellen Leibenluft, M.D. (M)
B17
Antidepressant Treatment and Adverse Events Among Suicidal Adolescents Following Hospitalization
Neera Ghaziuddin, M.D. (M)
University of Michigan
Ann Arbor, MI
Cheryl A. King, Ph.D.
Christopher R. Merchant, M.S.
Richard R. Dopp, M.D.
Richard M. Coates, M.D., MPH
B18
Altered Time-Pattern of Cortisol Associated with Higher Suicidality Among MDD Adolescents
Neera Ghaziuddin, M.D. (M)
University of Michigan
Ann Arbor, MI
Kathleen Welch, M.P.H., M.S.
Cheryl A. King, Ph.D.
B19
Comparative Efficacy of Atypical Antipsychotics for Pediatric Bipolar Disorder
Joseph Biederman, M.D. (M)
Massachusetts General Hospital
Boston, MA
B20
Efficacy and Safety of Guanfacine Extended Release (GXR) in ADHD
Joseph Biederman, M.D. (M)
Massachusetts General Hospital
Boston, MA
Andrew Lyne, M.Sc., C.Stat
Floyd R. Sallee, M.D., Ph.D. (M)
Timothy Whitaker, M.D.
B21
Responsiveness of Working Memory Measures to Methylphenidate in ADHD
Anne-Claude V. Bedard, Ph.D.
Hospital for Sick Children
Toronto, ON Canada
Sheilah Hogg-Johnson, Ph.D.
Jain Umesh, M.D., Ph.D. (M)
Rosemary R. Tannock, Ph.D.
B22
What is the Clinical Uitlity of the BRIEF in ADHD?
Anne-Claude V. Bedard, Ph.D.
Hospital for Sick Children
Toronto, ON Canada
Sheilah Hogg-Johnson, Ph.D.
Jain Umesh, M.D., Ph.D. (M)
Alison J. McInnes, Ph.D.
Maggie E. Toplak, Ph.D.
Margaret D. Weiss, M.D., Ph.D. (M)
Rosemary R. Tannock, Ph.D.
B23
CBCL Mania Proxy in Nonclinical Sample
M. Yanki Yazgan, M.D. (M)
Marmara University
Istanbul, Turkey
Selin Unal, M.A.
Ceyda Dedeoglu, M.A.
Beril Taskin, M.D.
Erman Caglar, B.A.
B24
Hemodynamic Differences Between ADHD Adults and Controls and Effects of Methylphenidate
M. Yanki Yazgan, M.D. (M)
Marmara University
Istanbul, Turkey
Ozgur Oner, M.D.
Koray Ciftci, M.D.
Ata Akin, M.D.
Duygu Bicer, M.D.
Bedriye Oncu, M.D.
Bulent Sankur, M.D.
Kerim Munir, M.D.
B25
Verbal Working Memory Impairments in Children and Adolescents with ADHD
Thomas E. Brown, Ph.D.
Yale University School of Medicine
New Haven, CT
Phillip C. Reichel
Donald M. Quinlan, Ph.D.
B26
Response Time Multisecond Oscillations in Children with Attention-Deficit/Hyperactivity Disorder
Adriana Di Martino, M.D.
New York University Child Study Center
New York, NY
Manely Ghaffari, M.D. (R)
Phil Reiss, Ph.D.
Christopher Hyde, Ph.D.
Jocelyn T. Curchack, B.A.
Eva Petkova, Ph.D.
Donald Klein, M.D.
Francisco Xavier Castellanos, M.D. (M)
B27
Behavioral Problems and Parenting Among Children with Autism and Their Siblings
Susan Shur-Fen Gau, M.D., Ph.D.
National Taiwan University Hospital
Taipei, Taiwan
B28
Treating Preschooler’s ODD in Pediatric Primary Care
John V. Lavigne, Ph.D.
Children’s Memorial Hospital
Chicago, IL
Susan A. LeBailley, Ph.D.
Karen R. Gouze, Ph.D.
Colleen Cicchetti, Ph.D.
Bryn W. Jessup, Ph.D.
Richard Arend, Ph.D.
Jonathan Pochyl, Ph.D.
Helen J. Binns, M.D.
B29
Juvenile Bipolar Disorder and ADHD: Comorbidity Study and Genome Scan
James J. McGough, M.D. (M)
UCLA - Semel Institute for Neuroscience and Human Behavior
Los Angeles, CA
Sandra K. Loo, Ph.D.
James T. McCracken, M.D. (M)
Jeffrey Dang, M.S.
Shaunna Clark, M.A.
Stanley F. Nelson, M.D.
Susan L. Smalley, Ph.D.
B30
Analysis of Sleep Effects in Children Treated with Once-daily Methylphenidate
Stephen V. Faraone, Ph.D.
SUNY Upstate Medical University
Syracuse, NY
Stephen J. Glatt, Ph.D.
Oscar G. Bukstein, M.D., M.P.H. (M)
Frank A. Lopez, M.D.
L. Eugene Arnold, M.D. (M)
Robert L. Findling, M.D. (M)
Jonathon Rubin, M.D., M.B.A.
B31
Cigarette Smoke Alters ADHD Candidate Gene Expression in Mice Brains
Stephen V. Faraone, Ph.D.
SUNY Upstate Medical University
Syracuse, NY
Tania Das Banerjee, M.S.
Frank A. Middleton, Ph.D.
Sheung P. Ng, Ph.D.
Judith T. Zelikoff, Ph.D.
B32
Gene Expression Pathways in Spontaneous and Environmentally-Induced ADHD Rat Models
Stephen V. Faraone, Ph.D.
SUNY Upstate Medical University
Syracuse, NY
Tania Das Banerjee, M.S.
Frank A. Middleton, Ph.D.
David F. Berger, Ph.D.
John P. Lombado, Ph.D.
Terje Sagvolden, Ph.D.
B33
Once-Daily Atomoxetine for Adult ADHD: A 6-Month, Double-Blind Trial
Lenard A. Adler, M.D.
New York University School of Medicine
New York, NY
Thomas J. Spencer, M.D. (M)
Thomas E. Brown, Ph.D.
James Holdnack, Ph.D.
Keith Saylor, Ph.D.
Martin Paczkowski, M.P.H.
Kory J. Schuh, Ph.D.
Paula T. Trzepacz, M.D.
Douglas K. Kelsey, M.D., Ph.D.
B34
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults with ADHD
Lenard A. Adler, M.D.
New York University School of Medicine
New York, NY
David W. Goodman, M.D.
Scott H. Kollins, Ph.D.
Richard H. Weisler, M.D.
Suma Krishnan, M.S.
Yuxin Zhang, Ph.D.
Joseph Biederman, M.D. (M)
B35
Recent Advances In The Assessment of Adult ADHD
Lenard A. Adler, M.D.
New York University School of Medicine
New York, NY
B38
Stimulant Rebound Effects Among Male Adolescent Drivers with ADHD
P. Melissa Moore, M.D. (M)
University of Virginia Department of Psychiatry and Neurobehavioral Sciences
Charlottesville, VA
Daniel J. Cox, Ph.D.
Roger C. Burket, M.D. (M)
R. Lawrence Merkel, M.D., Ph.D.
Amori Yee Mikami, Ph.D.
Boris Kovatchev, Ph.D.
B39
Effect of Methylphenidate on Variability in Response Time in ADHD
David A. Hayward, B.Sc., M.B.B.S., MRCPsych
University of Dundee
Dundee, Scotland
Sarah A. Seth, MBChB, MRCPsych
Sinead M. Rhodes, M.Litt, B.A., Ph.D.
Keith Matthews, M.D., Ph.D.
David R. Coghill, MBChB, M.D., MRCPsych (M)
B40
Adolescent ADHD: Atomoxetine Maintenance Effects on Age-Appropriate Developmental/Adaptive Functioning
Linda A. Wietecha, B.S.N., M.S.
Eli Lilly and Company
Indianapolis, IN
David W. Williams, M.S.
Michael Herbert, Ph.D.
Calvin R. Sumner, M.D.
Kory J. Shuh, Ph.D.
B41
Self-Observer Agreement of ADHD Symptoms in Adults
Nicole Heilbron, M.S.
Duke University Medical Center
Durham, NC
Kristina K. Hardy, Ph.D.
Scott H. Kollins, Ph.D.
Suzanne McMaster, Ph.D.
B42
ADHD Subtypes and Comorbidities: Differences in Sleep Problems
Susan D. Mayes, Ph.D.
Pennsylvania State College of Medicine
Hershey, PA
Susan L. Calhoun, M.S.
Edward O. Bixler, Ph.D.
Alexandros N. Vgontzas, M.D.
Jolene Hillwig-Garcia, M.D.
Fauzia Mahr, M.D.
Belal Elamir, M.D.
Linda Edhere-Ekezie, M.D.
Mathew Parvin, M.D.
Aimal Khan, M.D.
B43
Dihydroxyphenylglycol to Norepinephrine (DHPG/NE) Ratio Assessment in Treatment -Naïve ADHD Patients
Alonso G. Montoya, M.D.
Lilly Research Laboratories
Indianapolis, IN
Rodrigo Escobar, M.D.
Pepa Polavieja, B.S.
Inmaculada Gilaberte, M.D.
Jose Angel Alda, M.D.
Josep Artigas, M.D.
Xavier Gastaminza, M.D.
Esther Cardo, M.D.
B44
Caregivers of Children with ADHD Experience Significant Emotional Strain
Huabin F. Zhang, M.D.
McNeil Pediatrics Division of McNeil-PPC, Inc.
Fort Washington, PA
Xiaoying Xiao, Ph.D.
Susan C. Bolge, Ph.D.
B45
Adolescent ADHD Symptom Improvement with Triple-Bead Mixed Amphetamine Salts
Sharon B. Wigal, Ph.D.
University of California - Irvine
Irvine, CA
Ann Childress, M.D.
Tim Wigal, Ph.D.
Arthur Silverberg, Ph.D.
Sharon H. Youcha, M.D.
Heather Golarz, B.S.N., B.S.
B46
Efficacy and Cognitive Effects of Guanfacine Extended Release (GXR) in Children and Adolescents Aged 6 to 17
Years with Attention-Deficit/Hyperactivity Disorder (ADHD)
Scott H. Kollins, Ph.D.
Duke University Medical Center
Durham, NC
B47
Safety and Effects on Sleep of Guanfacine Extended Release (GXR) in Children and Adolescents Aged 6 to 17 years
with Attention-Deficit/Hyperactivity Disorder (ADHD)
Scott H. Kollins, Ph.D.
Duke University Medical Center
Durham, NC
B48
Guanfacine Extended Release (GXR) in ADHD: Efficacy and Cognitive Effects
Scott H. Kollins, Ph.D.
Duke University Medical Center
Durham, NC
Tim Wigal, Ph.D.
Bradley Vince, D.O.
John Turnbow, M.D.
Andrew Lyne, M.Sc., C.Stat
Kimberly Fiske, B.S., MPH
B49
Defining ADHD Phenotypes: Any Questionnaire Will Do... Or Will It?
Arthur D. Anastopoulos, Ph.D.
University of North Carolina - Greensboro
Greensboro, NC
Lisa DeGrass, M.A.
Jennifer L. Sommer, M.A.
Erin M. Kane, M.A.
Scott H. Kollins, Ph.D.
Melanie E. Kail, M.S.
Michael L. Cuccaro, Ph.D.
Allison Ashley-Koch, Ph.D.
B50
Personal, Economic and Sexual Outcomes Associated with Childhood ADHD
Sarah W. Ball, M.P.H., M.S., Sc.D.
Harvard School of Public Health
Boston, MA
Eric O. Mick, Sc.D.
B51
Medication Use Among Puerto Rican Children With and Without ADHD at Two Sites
Hector R. Bird, M.D. (M)
Columbia University
New York, NY
Patrick E. Shrout, Ph.D.
Glorisa J. Canino, Ph.D.
Cristiane S. Duarte, Ph.D.
Jose J. Bauermeister, Ph.D.
Sa Shen, Ph.D.
B52
Symptomatic Versus Functional Changes in Children and Adolescents with ADHD
Jan K. Buitelaar, M.D., Ph.D. (M)
Radboud University Nijmegan Medical Center
Nijmegan, The Netherlands
B53
Quality of Life in a Randomized ADHD Drug Trial
Michael T. Cannon, Ph.D.
University of Cleveland Hospital
Cleveland, OH
Floyd R. Sallee, M.D., Ph.D. (M)
B54
Validity of the Children’s Organizational Skills Scale (COSS)
Marisa D. Catapang, B.Sc.
Hospital for Sick Children
Toronto, ON Canada
Anne-Claude V. Bedard, Ph.D.
Min-Na Hockenberry, M.A.
Alison J. McInnes, Ph.D.
Rosemary R. Tannock, Ph.D.
B55
Fixed-Dose Titration Study of Dexmethylphenidate Extended Release in Children with ADHD
Ann Childress, M.D.
Center for Psychiatric Research and Behavioral Medicine
Las Vegas, NV
Rafael Muniz, M.D.
Janice Miller, M.D. (M)
Valerie K. Arnold, M.D. (M)
Linda Harper, M.D. (M)
Ortrud Gerstner, M.Sc.
Mary Borello, R.N.
Anuradha Thulasiraman, M.A.
Anke Post, M.D.
B56
Sleep Disordered Breathing, Excessive Sleepiness, and ADHD Traits in Obese Children
Samuele Cortese, M.D.
Hospital Robert Debre
Paris, France
B57
Factor Structure of DSM-IV ADHD Symptoms in Adults
Melanie A. Fernandez, M.S.
Duke University Medical Center
Durham, NC
Kristina K. Hardy, Ph.D.
Scott H. Kollins, Ph.D.
Suzanne McMaster, Ph.D.
B58
Working Memory and Academics in College Students with ADHD
Rachel J. Gropper, B.A.
University of Toronto
Toronto, ON Canada
Rosemary R. Tannock, Ph.D.
B59
QoL of Atomoxetine and Psychoeducation in an ADHD Double-Blind Trial
Par Svanborg, M.D., Ph.D.
Eli lilly Sweden
Solna, Sweden
Gunilla Thernlund, M.D., Ph.D.
Per A. Gustafsson, M.D.
Bruno Hagglof, M.D., Ph.D.
Lynne Poole, M.S.C.
Bjorn Kadesjo, M.D., Ph.D.
B60
Long-Term (Up to 12 Months) Use of the Methylphenidate Transdermal System
Frank A. Lopez, M.D.
Children’s Developmental Center, P.A.
Maitland, FL
Oscar G. Bukstein, M.D., M.P.H. (M)
Robert L. Findling, M.D. (M)
John Turnbow, M.D.
Jonathon Rubin, M.D., M.B.A.
B61
Long-Duration Stimulant Treatment of ADHD in Preschoolers - Feasibility Study
Lawrence A. Maayan, M.D. (M)
New York State Psychiatric Institute
New York, NY
Lisa A. Kotler, M.D. (M)
Natalya Paykina, M.A.
Tara A. Strauss, B.A.
Jane E. Fried, M.D.
Laurence L. Greenhill, M.D. (M)
